Horizontal gene transfer and silver nanoparticles production in a new Marinomonas strain isolated from the Antarctic psychrophilic ciliate Euplotes focardii

Maria Sindhura John, Joseph Amruthraj Nagoth, Kesava Priyan Ramasamy, Patrizia Ballarini, Matteo Mozzicafreddo, Alessio Mancini, Andrea Telatin, Píetro Lió, Gabriele Giuli, Antonino Natalello, Cristina Miceli, Sandra PucciarelliScientific 2020 · DOI

Abstract

Researchers have isolated a novel bacterial strain, Marinomonas sp. ef1, from a prokaryotic consortium associated with the Antarctic psychrophilic ciliate Euplotes focardii. Phylogenetic analysis reveals a close relationship to other Antarctic marine bacteria, specifically M. polaris. Whole-genome sequencing identified five genomic islands likely acquired through horizontal gene transfer (HGT), including genes for the nitroreductase superfamily. These enzymes enable the bacterium to perform "green synthesis" of silver nanoparticles (AgNPs) at a mild 22°C. The resulting nanoparticles (30–50 nm) are naturally stabilized by bacterial proteins and exhibit potent antimicrobial activity against common human pathogens while remaining non-toxic to human skin cells.

Introduction

The global threat of multi-drug resistant "superbugs" has accelerated the search for alternative antimicrobial agents. Silver nanoparticles (AgNPs) are highly effective against a broad spectrum of bacteria and fungi. However, traditional industrial production relies on energy-intensive physico-chemical methods involving toxic reducing agents. This study investigates the extreme environment of the Antarctic to find specialized microbes capable of sustainable, biological nanoparticle production.

Methods and Genomic Analysis

The new strain, Marinomonas sp. ef1, was isolated from the ciliate Euplotes focardii and characterized using 16S rDNA sequencing and Whole Genome Sequencing (WGS). Bioinformatics tools were employed to identify Genomic Islands (GEIs)—clusters of genes acquired from other species via HGT.

For biosynthesis, bacterial biomass was incubated with 1 mM silver nitrate (AgNO3) at 22°C. The resulting AgNPs were purified and characterized using Transmission Electron Microscopy (TEM), X-ray Diffraction (XRD), and Fourier Transform Infrared (FTIR) spectroscopy. Biological efficacy was measured against 12 clinical pathogens, and biocompatibility was assessed using human dermal fibroblast (NHDF) assays.

Horizontal Gene Transfer and Metabolic Adaptation

A key finding of the study is that the ability to produce AgNPs is likely an acquired trait. Marinomonas sp. ef1 possesses specific enzymes, such as the nitroreductase YfkO, located within genomic islands. These "borrowed" genes allow the bacterium to detoxify silver ions by converting them into solid nanoparticles. This mechanism may provide a dual ecological benefit: detoxifying the immediate environment and protecting the host ciliate from pathogenic infections.

Phylogenetic analysis of proteins potentially acquired via horizontal gene transfer, including integrases and nitroreductases.

While HGT is evident, the authors noted that definitively identifying the donor organisms remains challenging due to faint evolutionary signals in some gene clusters.

Nanoparticle Characterization and Efficacy

The biosynthesized AgNPs were spherical, relatively small, and highly stable. FTIR analysis confirmed that the particles are naturally "capped" by bacterial proteins, which prevents aggregation and likely enhances their biological stability.

Characterization of biosynthesized AgNPs: (B) Particle size distribution showing a peak at approximately 30 nm; (D) Apparent zeta potential showing a stable negative charge.

Key results include:

  • Size and Stability: Average particle size of 30–50 nm with a negative zeta potential of -27.1 mV.
  • Antimicrobial Potency: The AgNPs outperformed conventional antibiotics like Ampicillin against several pathogens, including S. aureus and E. coli. The Minimum Inhibitory Concentration (MIC) was as low as 3.12 µg/ml for Proteus mirabilis.
  • Biocompatibility: At therapeutic concentrations (below 10 µg/ml), the nanoparticles showed no significant cytotoxic effect on human dermal fibroblasts, suggesting potential for topical medical applications.

Conclusion

This research provides the first report of AgNP biosynthesis by a Marinomonas strain. By leveraging genes acquired through horizontal gene transfer, Marinomonas sp. ef1 serves as an efficient microbial factory for producing stable, bioactive nanoparticles. These findings highlight the potential of Antarctic microbiota as a source for sustainable biotechnological solutions in the fight against antibiotic resistance.

Summary updated

Abstract

We isolated a novel bacterial strain from a prokaryotic consortium associated to the psychrophilic marine ciliate Euplotes focardii, endemic of the Antarctic coastal seawater. The 16S rDNA sequencing and the phylogenetic analysis revealed the close evolutionary relationship to the Antarctic marine bacterium Marinomonas sp. BSw10506 and the sub antarctic Marinomonas polaris. We named this new strain Marinomonas sp. ef1. The optimal growth temperature in LB medium was 22 °C. Whole genome sequencing and analysis showed a reduced gene loss limited to regions encoding for transposases. Additionally, five genomic islands, e.g. DNA fragments that facilitate horizontal gene transfer phenomena, were identified. Two open reading frames predicted from the genomic islands coded for enzymes belonging to the Nitro-FMN-reductase superfamily. One of these, the putative NAD(P)H nitroreductase YfkO, has been reported to be involved in the bioreduction of silver (Ag) ions and the production of silver nanoparticles (AgNPs). After the Marinomonas sp. ef1 biomass incubation with 1 mM of AgNO<sub>3</sub> at 22 °C, we obtained AgNPs within 24 h. The AgNPs were relatively small in size (50 nm) and had a strong antimicrobial activity against twelve common nosocomial pathogenic microorganisms including Staphylococcus aureus and two Candida strains. To our knowledge, this is the first report of AgNPs biosynthesis by a Marinomonas strain. This biosynthesis may play a dual role in detoxification from silver nitrate and protection from pathogens for the bacterium and potentially for the associated ciliate. Biosynthetic AgNPs also represent a promising alternative to conventional antibiotics against common pathogens.
BibTeX
@inproceedings{john2020horizontal,
  author = {Maria Sindhura John and Joseph Amruthraj Nagoth and Kesava Priyan Ramasamy and Patrizia Ballarini and Matteo Mozzicafreddo and Alessio Mancini and Andrea Telatin and Píetro Lió and Gabriele Giuli and Antonino Natalello and Cristina Miceli and Sandra Pucciarelli},
  title = {{Horizontal gene transfer and silver nanoparticles production in a new Marinomonas strain isolated from the Antarctic psychrophilic ciliate Euplotes focardii}},
  booktitle = {Scientific},
  year = {2020},
  doi = {10.1038/s41598-020-66878-x},
}
Figure